Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NGNE

Neurogene Inc.

CIK 0001404644 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$42.84
↑ 4.60 (12.03%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$676.95M
P/E Ratio
-6.86
EPS
-4.24
Dividend Yield
Not covered
52W Position
97%
Beta
1.59

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.85
P/S
Not covered
EV/Revenue
Not covered
ROE
-41.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 97%
$15.93$43.66

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$90.35M
Total Assets
$288.60M
Free Cash Flow
-$78.36M

Recent news